Literature DB >> 4000517

Reconstruction of large bone defects with calcium phosphate ceramics--an experimental study.

P Patka, G den Otter, K de Groot, A A Driessen.   

Abstract

The aim of the present study is to evaluate the bone-defect-repairing capacity of dense hydroxyapatite compared with 40% macroporous hydroxyapatite in a weight-bearing model. The experiment consisted of the production of a relatively large mid-diaphysary defect in the left femur of 18 mongrel dogs. Cylindrical and semicylindrical hydroxyapatite implants were placed in these bone defects in order to restore continuity. The biocompatibility of implanted material has been studied physiologically, by radiographs and scintigraphs, by histology and finally by biomechanical tests. The normal weight-bearing of the operated limb restored in three weeks time. There were two mechanical failures in dense cylindric implants and two in porous cylindric implants. Radiographically, no evidence was found of degradation of porous or dense implants. Radionuclide bone imaging to assess osseous changes at the site of implants, showed intense radionuclide accumulation in all recordings of porous implants up to two years after implantation, in contrast to dense implant recordings. Histologically, there was no evidence of bioresorption. The implants were in direct contact with normal bone tissue. The pores were filled by calcified bone. There were no differences between porous and dense implants concerning the biocompatibility of hydroxyapatite.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4000517

Source DB:  PubMed          Journal:  Neth J Surg        ISSN: 0167-2487


  3 in total

1.  Mesenchymal stem cells combined with biphasic calcium phosphate ceramics promote bone regeneration.

Authors:  T L Livingston; S Gordon; M Archambault; S Kadiyala; K McIntosh; A Smith; S J Peter
Journal:  J Mater Sci Mater Med       Date:  2003-03       Impact factor: 3.896

2.  Experimental research on the use of an antineoplastic drug with a bone implant.

Authors:  W Y Guan; W T Yi; M Y Zhi; S S Zhen
Journal:  Int Orthop       Date:  1990       Impact factor: 3.075

3.  An animal model in sheep for biocompatibility testing of biomaterials in cancellous bones.

Authors:  Katja M R Nuss; Joerg A Auer; Alois Boos; Brigitte von Rechenberg
Journal:  BMC Musculoskelet Disord       Date:  2006-08-15       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.